Article

Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic.

Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, USA.
The Journal of Comparative Neurology (impact factor: 3.81). 03/2008; 506(4):616-26. DOI:10.1002/cne.21576 pp.616-26
Source: PubMed

ABSTRACT Interactions between stress and the mesocorticolimbic dopamine (DA) system have been suggested from behavioral and electrophysiological studies. Because corticotropin-releasing factor (CRF) plays a role in stress responses, we investigated possible interactions between neurons containing CRF and those producing DA in the ventral tegmental area (VTA). We first investigated the cellular distribution of CRF in the VTA by immunolabeling VTA sections with anti-CRF antibodies and analyzing these sections by electron microscopy. We found CRF immunoreactivity present mostly in axon terminals establishing either symmetric or asymmetric synapses with VTA dendrites. We established that nearly all CRF asymmetric synapses are glutamatergic, insofar as the CRF-immunolabeled axon terminals in these synapses coexpressed the vesicular glutamate transporter 2, and that the majority of CRF symmetric synapses are GABAergic, insofar as the CRF-immunolabeled axon terminals in these synapses coexpressed glutamic acid decarboxylase, findings that are of functional importance. We then looked for synaptic interactions between CRF- and DA-containing neurons, by using antibodies against CRF and tyrosine hydroxylase (TH; a marker for DA neurons). We found that most synapses between CRF-immunoreactive axon terminals and TH neurons are asymmetric (in the majority likely to be glutamatergic) and suggest that glutamatergic neurons containing CRF may be part of the neuronal circuitry that mediates stress responses involving the mesocorticolimbic DA system. The presence of CRF synapses in the VTA offers a mechanism for interactions between the stress-associated neuropeptide CRF and the mesocorticolimbic DA system.

0 0
 · 
0 Bookmarks
 · 
40 Views
  • Source
    Article: Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems.
    [show abstract] [hide abstract]
    ABSTRACT: Allostasis, originally conceptualized to explain persistent morbidity of arousal and autonomic function, is defined as the process of achieving stability through physiological or behavioral change. Two types of biological processes have been proposed to describe the mechanisms underlying allostasis in drug addiction, a within-system adaptation and a between-system adaptation. In the within-system process, the drug elicits an opposing, neutralizing reaction within the same system in which the drug elicits its primary and unconditioned reinforcing actions, while in the between-system process, different neurobiological systems that the one initially activated by the drug are recruited. In this review, we will focus our interest on alterations in the dopaminergic and corticotropin releasing factor systems as within-system and between-system neuroadaptations respectively, that underlie the opponent process to drugs of abuse. We hypothesize that repeated compromised activity in the dopaminergic system and sustained activation of the CRF-CRF1R system with withdrawal episodes may lead to an allostatic load contributing significantly to the transition to drug addiction.
    Physiology & Behavior 11/2011; 106(1):58-64. · 2.87 Impact Factor

Keywords

corticotropin-releasing factor
 
CRF asymmetric synapses
 
CRF immunoreactivity present
 
CRF-immunolabeled axon terminals
 
CRF-immunoreactive axon terminals
 
electrophysiological studies
 
immunolabeling VTA sections
 
Interactions
 
majority likely
 
mediates stress responses
 
mesocorticolimbic DA system
 
possible interactions
 
producing DA
 
stress responses
 
stress-associated neuropeptide CRF
 
synapses coexpressed
 
synapses coexpressed glutamic acid decarboxylase
 
synaptic interactions
 
ventral tegmental area
 
vesicular glutamate transporter 2
 

Patricia Tagliaferro